Developing new treatments for tuberculosis


Fighting TB, a disease that kills more than 1.5 million people every year


A single product, multiple indications


A GMP Plant to offer specialized services to biotech industry


Archivel Farma is a R&D biotech company that develops immunotherapeutic agents to respond to unmet medical needs

Development, Manufacturing and Analytical Services

Archivel Farma offers a wide range of services to help biotech and pharma companies to develop and scale up their projects.

– More information

Development, Manufacturing and Analytical Services

– More information


STriTuVaD-Consortium-ArchivelFarma ArchivelGeneralPress release

The STriTuVaD Consortium is proud to announce the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for Tuberculosis (TB)

The Spanish biotech company Archivel Farma has officially begun the clinical trial of its therapeutic vaccine RUTI®, which will be carried out by Clinical Research Network India, a Contract Research…
ArchivelPress releaseResearch

Archivel Farma’s RUTI® vaccine to start a clinical trial to increase the immunity of healthcare professionals exposed to the risk of COVID-19

The clinical trial will be carried out at the Germans Trias i Pujol Hospital in Badalona (Can RUTI), and it will include 300 healthy health professionals in direct contact with…

Extension of the authorization for the manufacture of medicines

As of 30th October 2019, Archivel Farma has obtained from the Spanish Health Authority the authorization as Manufacturer for Sterile investigational medicinal products for terminal sterilised operations of Solids and Implants…